Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
11,181,416
-
Total 13F shares
-
31,761,826
-
Share change
-
-1,305,143
-
Total reported value
-
$42,558,064
-
Price per share
-
$1.34
-
Number of holders
-
41
-
Value change
-
-$1,719,668
-
Number of buys
-
11
-
Number of sells
-
19
Institutional Holders of Ikena Oncology, Inc. - Common Stock, $0.001 par value (IKNA) as of Q2 2025
As of 30 Jun 2025,
Ikena Oncology, Inc. - Common Stock, $0.001 par value (IKNA) was held by
41 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,761,826 shares.
The largest 10 holders included
Atlas Venture Life Science Advisors, LLC, Blue Owl Capital Holdings LP, BML Capital Management, LLC, BVF INC/IL, ORBIMED ADVISORS LLC, Deep Track Capital, LP, Omega Fund Management, LLC, VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., and NEA Management Company, LLC.
This page lists
41
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.